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Abstract. Currently in HDR brachytherapy planning, a manual fine-tuning of an
objective function is necessary to obtain case-specific valid plans. This study intends
to facilitate this process by proposing a patient-specific inverse planning algorithm for
HDR prostate brachytherapy: GPU-based multi-criteria optimization (gMCO).
Two GPU-based optimization engines including simulated annealing (gSA) and a
quasi-Newton optimizer (gL-BFGS) were implemented to compute multiple plans in
parallel. After evaluating the equivalence and the computation performance of these
two optimization engines, one preferred optimization engine was selected for the gMCO
algorithm. Five hundred sixty-two previously treated prostate HDR cases were divided
into validation set (100) and test set (462). In the validation set, the number of Pareto
optimal plans to achieve the best plan quality was determined for the gMCO algorithm.
In the test set, gMCO plans were compared with the physician-approved clinical plans.
Our results indicated that the optimization process is equivalent between gL-BFGS
and gSA, and that the computational performance of gL-BFGS is up to 67 times faster
than gSA. Over 462 cases, the number of clinically valid plans was 428 (92.6%) for
clinical plans and 461 (99.8%) for gMCO plans. The number of valid plans with target
V100 coverage greater than 95% was 288 (62.3%) for clinical plans and 414 (89.6%) for
gMCO plans. The mean planning time was 9.4 s for the gMCO algorithm to generate
1000 Pareto optimal plans.
In conclusion, gL-BFGS is able to compute thousands of SA equivalent treatment
plans within a short time frame. Powered by gL-BFGS, an ultra-fast and robust multi-
criteria optimization algorithm was implemented for HDR prostate brachytherapy.
Plan pools with various trade-offs can be created with this algorithm. A large-
scale comparison against physician approved clinical plans showed that treatment plan
quality could be improved and planning time could be significantly reduced with the
proposed gMCO algorithm.
Keywords: brachytherapy, prostate cancer, patient-specific, treatment planning,
optimization, GPU
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1 Introduction
About 52.3% of non-skin cancer patients receive radiation therapy during the course of
their illness (Citrin 2017, DeVita et al 2015, Delaney et al 2005). The most common
radiation therapy treatment particle type used is the photon, which can be delivered
either externally from a medical linear accelerator (External Beam Radiation Therapy
- EBRT) or internally from an inserted small radioactive source (brachytherapy, high
dose rate (HDR) or low dose rate (LDR)).
Dose prescriptions in modern radiation treatment planning contain both tumor and
healthy organ objectives. These objectives are often conflicting and can be generalized
as: treating the tumor with high radiation dose and sparing the healthy organs with
low radiation dose. Computerized treatment planning systems were used to formulate
clinical prescriptions into a mathematical optimization problem, and to find treatment
plans that well presented these prescriptions with treatment facilities.
However, most available algorithms are not inherently patient-specific in a sense
that manual re-plannings are usually inevitable to find a clinically acceptable plan for
each patient. As a result, the planning procedure can be time consuming and the
planning output is planner dependant (Moore et al 2011, Nelms et al 2012, Wu et al
2009).
Several patient-specific inverse planning algorithms such as knowledge-based
planning (KBP), auto-planning (AP) and multi-criteria optimization (MCO) have been
proposed in EBRT. In KBP, one plan is created for a new case by searching in a prior
physician-approved plan dataset based on the geometric features (Moore et al 2011, Wu
et al 2011, Wu et al 2009, Petit et al 2012). In AP, a clinical plan can be obtained
by interactively and automatically adapting objectives, constraints and dose shaping
contours (Hazell et al 2016). In MCO, a plan pool is constructed by generating plans
with various trade-offs on Pareto surfaces (Craft et al 2006, Teichert et al 2011).
Similar studies can also be found in brachytherapy (van der Meer et al 2018, Shen et
al 2018, Zhou et al 2017, Cui et al 2018a, Cui et al 2018b).
Our prior studies (Cui et al 2018a, Cui et al 2018b) showed that a patient-
specific treatment plan can be created without any user interventions in HDR prostate
brachytherapy. However, the optimization engine of these studies was stochastic, and
was implemented on CPU hardware (Cui et al 2018a, Cui et al 2018b). As a result,
the algorithm inevitably involved an intensive computation (41 s), which may restrain
its application in clinical practice, because the patient is under general anesthesia in the
operating room waiting for the treatment to be delivered.
The capability of graphics processing unit (GPU) architecture in reducing
calculation time in medical physics were reviewed in (Pratx and Xing 2011, Jia et al
2014, Despre´s and Jia 2017). The purpose of this study is to propose an ultra-fast
patient-specific inverse planning algorithm on GPU for HDR brachytherapy.
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2 Methods and Materials
This section begins with a detailed description of experimental setups including patient
selection, mathematical formulations and computational specifications. Next, two
inverse planning optimization engines were implemented on GPU architecture to
calculate multiple plans in parallel and to populate the Pareto surfaces. Powered by
the preferred optimization engine, a GPU-based multi-criteria optimization algorithm
(gMCO) which is able to automatically generate clinical plans was proposed to
eliminate the re-planning problem in HDR brachytherapy. In the end, a comprehensive
comparison, including dosimetric performance as well as planning time, between clinical
plans and gMCO plans was made.
2.1 Experimental setup
2.1.1 Patient selection An anonymous dataset that contains 562 prostate cancer
patients who received an HDR brachytherapy treatment as a boost to EBRT from
April 2011 to July 2016 at our institution was studied. This dataset incorporates the
cases studied in prior works (Edimo et al 2019, Cui et al 2018a, Cui et al 2018b).
Among the dataset, 100 random cases (validation set) were used to determine the
number of Pareto optimal plans with the gMCO algorithm, and 462 random cases (test
set) were used in the performance evaluation of the gMCO generated plans.
After inserting 16-18 plastic catheters into the prostate under a transrectal
ultrasound guidance, the anatomy of these patients was obtained from CT scans.
Organ structures (prostate, urethra, bladder and rectum) were delineated and were
imported into a commercial treatment planning system (Elekta Oncentra Brachy IPSA,
Veenendaal, The Netherlands). The prescription was to deliver 15 Gy in a single fraction
to the prostate. Plans were delivered using a Flexitron afterloader (Elekta Brachy,
Veenendaal, The Netherlands) with an Ir-192 radioactive source.
The dwell positions were extracted from the DICOM-RT files of clinical plans,
and the mean number of active dwell positions (Nact) used for the optimization
was 171 (range:102-385). The mean number of dose calculation points (Npnt) used
for the optimization was 5913 (range:2753-15 998), and the mean number of dose
calculation points used for the dose-volume histogram (DVH) computations was 31 039
(range:11 451-66 089).
2.1.2 Quadratic objective function formulation Inverse Planning Simulated Annealing
(IPSA) (Lessard and Pouliot 2001) was used as a dose optimization engine in our prior
studies (Cui et al 2018a, Cui et al 2018b). In IPSA, piecewise linear objective functions
were solved with simulated annealing (Lessard and Pouliot 2001), a stochastic optimizer.
These objective functions were constructed with a population based planning template
called a class solution (Cui et al 2018a, Cui et al 2018b).
In order to implement an efficient optimizer, one option is to replace the stochastic
optimizer with a gradient-based optimizer. Therefore, it may be necessary to replace
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the IPSA linear piecewise objective functions with piecewise quadratic objective
functions, so that the first derivative (gradient) of the objective function is continuous.
Quadratic objective functions are usually solved with gradient-based optimizers in
radiation therapy (Milickovic et al 2002, Lahanas, Baltas and Giannouli 2003, Lahanas,
Schreibmann and Baltas 2003, Men et al 2009).
The dose at the ith dose calculation point in the jth organ, denoted by dij, is
described in equation (1)
dij =
Nact∑
l=1
d˙ijltl (1)
where d˙ijl is the dose rate contribution of the l
th dwell position to the ith dose calculation
point in the jth organ, and tl is the dwell time of the l
th dwell position. In order to
avoid negative dwell times, new decision variables called dwell weight (xl = t
1/2
l ) were
introduced as in (Milickovic et al 2002, Lahanas, Baltas and Giannouli 2003). With
this substitution, the dwell times are always non-negative (tl = x
2
l ).
The piecewise quadratic objective function fij at the i
th dose calculation point of
the jth organ is given in equation (2)
fij(dij) =

wmin · (Dmin − dij)2 dij < Dmin
0 Dmin ≤ dij ≤ Dmax
wmax · (dij −Dmax)2 dij > Dmax .
(2)
Variables Dmin and Dmax are the underdose limit and the overdose limit respectively,
and variables wmin and wmax are the corresponding weights. The corresponding gradient
function gij of equation (2) is described in equation (3)
gij(xl) =
∂fij
∂xl
=

4 · d˙ijl · xl · wmin · (dij −Dmin) dij < Dmin
0 Dmin ≤ dij ≤ Dmax
4 · d˙ijl · xl · wmax · (dij −Dmax) dij > Dmax .
(3)
The single joint MCO objective function to be minimized is defined as a weighted
sum in equation (4)
F =
NO∑
j=1
wj · 1
Npnt,j
Npnt,j∑
i=1
fij(dij) (4)
where NO is the number of organs, Npnt,j is the number of dose calculation points in
the jth organ. wj is a hidden weight applied to the objectives (surface and volume) of
the jth organ to introduce trade-off in the solution space around the population-based
starting point as in (Cui et al 2018a, Cui et al 2018b). The hidden weights are always
non negative and their sum is one (because of the weighted sum method).
The original class solution designed for the piecewise linear objective functions (Cui
et al 2018a, Cui et al 2018b) will no longer be appropriate to construct the new
quadratic objective functions, and so a new one must be designed (table 1).
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Table 1: The class solution to formulate quadratic objective functions (equation (2)) for
15 Gy prostate boost HDR treatment (Surface: surface dose calculation points, Volume:
volume dose calculation points).
Organ
Surface Volume
wmin Dmin(Gy) Dmax(Gy) wmax wmin Dmin(Gy) Dmax(Gy) wmax
Target 200 15 22.5 80 200 15 22.5 1
Urethra 30 14 16 160 30 14 16 160
Bladder 0 0 7.5 60 0 0 7.5 60
Rectum 0 0 7.5 15 0 0 7.5 15
2.1.3 Computational specifications The CPU algorithm was written in C++,
compiled with g++ (7.3.0) and executed on a six-core Intel Xeon CPU (E5-2620 v3
@ 2.40 GHz). The GPU algorithms were written in CUDA C, compiled with nvcc
(CUDA toolkit 10.0.130) and executed on an NVIDIA Titan X (Pascal) GPU.
2.2 GPU-based efficient optimization engines
Previous studies showed that it is feasible to find clinically acceptable treatment plans
after exploring Pareto surfaces with MCO approaches (Craft et al 2006, Cui et al
2018a). However, constructing Pareto surfaces could be inefficient, if performed
sequentially.
2.2.1 IPSA on GPU A traditional CPU-based inverse planning algorithm such as
IPSA (or cSA) (Lessard and Pouliot 2001) can be divided into several serial computing
steps (figure 1). In each step, the same operation is repeated over a large dataset. For
example, the following five steps are essential in cSA:
(i) Initialization and dose rate matrix calculation (repeated for: Npnt dose calculation
points × Nact dwell positions),
(ii) dwell time updates (repeated for: Nact dwell positions),
(iii) dose calculations based on equation (1) (repeated for: Npnt dose calculation points),
(iv) objective function values calculation based on equation (2) (repeated for: Npnt dose
calculation points),
(v) mean objective function evaluation based on equation (4) (repeated for: one
accumulation over Npnt dose calculation points).
To obtain an optimal solution or a treatment plan, steps (ii)-(v) are iteratively
repeated in cSA. Furthermore, in order to explore Pareto surfaces by computing Nplan
treatment plans, it is usually necessary to repeat the aforementioned steps Nplan times.
To increase the efficiency of MCO approaches, GPU-based IPSA (or gSA) was
implemented on GPU architecture to compute treatment plans with various trade-offs
in parallel. Two strategies were applied to achieve this purpose.
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(ii) Dwell time updates
t 1
1t 1 t N act...
d1 d N pnt...
f 1 f N pnt...
F= 1
N pnt
∑i
N pnt f i
CPU
t N act
1 t 1
N plan tN act
N plan... ... ...
(iii) Dose calculations
d1
1 d N pnt
1 d1
N plan d N pnt
N plan... ... ...
f 1
1 f N pnt
1 f 1
N plan f N pnt
N plan... ... ...
(iv) Objective function values calculation
(v) Mean objective function evaluation
F1= 1
N pnt
∑i
N pnt f i
1 FN plan= 1
N pnt
∑i
N pnt f i
N plan...
Nplan x Nact threads
Nplan x Npnt threads
Nplan x Npnt threads
Nplan threads
(i) Initialization and dose rate matrix calculation
d˙11 ... ... ...d˙1 N pnt d˙ N act 1 d˙ N act N pnt
GPU
Figure 1: Illustration of the iterative procedure to optimize one treatment plan on
CPU and Nplan plans on GPU. In each CPU or GPU iteration, the steps (ii)-(v) are
executed sequentially. In each step on the CPU, the operations are executed sequentially
in a loop. In each step on the GPU, the operations are executed in parallel on different
threads for Nplan plans. (The superscript indicates the plan number on GPU).
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First, the serial operations computed in each step in cSA were adapted to run in
parallel on GPU, so the operations within each step can be executed simultaneously on
different threads (figure 1). Note that in each step on GPU, the computational burden
is Nplan times larger than in the CPU implementation (Nplan plans on GPU vs. one
plan on CPU in figure 1). However, a performance gain can be achieved with the GPU
implementation, as the huge burden of updating the values for all plans in each step
is processed in parallel on different threads. To obtain Nplan optimal solutions or Nplan
treatment plan with the proposed implementation, it is necessary to iteratively repeat
steps (ii)-(v) in gSA.
Second, as frequent data transfers between CPU and GPU will slow down the
computation, data transfer only occurs twice in gSA: once when preparing the data
used for the optimization (CPU to GPU), once more when saving the dosimetric results
onto the disk after the optimization (GPU to CPU).
2.2.2 Deterministic optimizer In section 2.2.1, a stochastic optimizer was imple-
mented on CPU and on GPU. To further improve the computational performance,
a deterministic optimizer (Limited-memory Broyden-Fletcher-Goldfarb-Shanno, L-
BFGS) (Liu and Nocedal 1989, Wetzl and Taubmann 2013, Wetzl et al 2013) was
introduced to replace the stochastic optimizer. There are two reasons to choose this
quasi-Newton optimizer, (1) BFGS and its variants are widely studied in brachyther-
apy (Milickovic et al 2002, Lahanas, Baltas and Giannouli 2003), and (2) L-BFGS is
widely used in clinic after being integrated in Hybrid Inverse Planning Optimization
(HIPO) (Elekta Brachy, Veenendaal, The Netherlands) (Karabis et al 2005).
So far, four optimization engines were implemented: cSA, gSA (simulated annealing
on CPU and on GPU), cL-BFGS and gL-BFGS (L-BFGS on CPU and on GPU). The
description of L-BFGS implementation on CPU and on GPU is omitted in this study,
due to the similarity with the context and figure 1 in section 2.2.1.
2.2.3 Equivalence between the four optimizers The equivalence between the four
optimization engines was evaluated based on the same objective function (class solution
in table 1) as tested over the validation set. For cSA, gSA, and cL-BFGS, one plan
using uniform 5 s initial dwell times as a starting point was generated. For gL-BFGS,
1000 degenerated plans were calculated to evaluate the convergence of different starting
points (randomly distributed between 0 and 10 s). The stopping criteria for cSA and
gSA was specified by the number of iterations. The stopping criteria for cL-BFGS
and gL-BFGS was specified by the parameter  (based on the relative variation of the
objective function (Men et al 2009)). To measure the equivalence between the four
optimizers, 1 000 000 iterations and  = 10−7 were used as the stopping criteria, because
no significant improvements in the objective function were observed.
2.2.4 Pareto surfaces characterization with gSA and gL-BFGS Planning efficiency is
a key factor when designing an inverse planning algorithm. For SA, a clinically useful
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stopping criteria (50 000 iterations) can be used to reach Pareto surfaces (Cui et al
2018a). For gradient-based method, it is also desirable to find a stopping criteria that
can well approximate the Pareto surfaces.
By computing solutions in parallel with various combinations of hidden weights,
Pareto surfaces can be populated either with gSA and with gL-BFGS. Such solutions
were Pareto optimal, or non-dominated, if no solution that improves any individual
objective value without worsening at least one of the other individual objective values
exists. A clinically useful stopping criteria was determined for gL-BFGS to approximate
the Pareto surfaces, after examining the effect of different stopping criteria (ranging from
 = 10−7 to  = 10−2) based on the fraction of non-dominated solutions and the speedup
factor of the optimization time for all 100 validation cases.
2.2.5 Computational performance under clinically useful scenarios The benefits of
the proposed GPU implementation over a traditional CPU implementation of inverse
planning algorithms were explored. Based on the clinically useful stopping criteria,
the computational performance of cSA, gSA, cL-BFGS and gL-BFGS were measured
against the number of generated plans.
2.3 Patient-specific multi-criteria optimization algorithm
Usually, plans obtained with a population-based planning template are not always
directly acceptable, and manual weights adjustments are required to obtain a patient-
specific deliverable plan. After reviewing the definition of acceptable plans, a GPU-based
multi-criteria optimization algorithm (gMCO) powered with gL-BFGS was proposed to
eliminate the procedure of manual weights adjustments.
2.3.1 Plan evaluation The schedules of dose fractionation and the evaluation criteria
of HDR prostate brachytherapy plans may vary between centers (Yamada et al 2012).
According to the Radiation Therapy Oncology Group (RTOG) 0924 protocol (Radiation
Therapy Oncology Group 2016), RTOG acceptable plans (or valid solutions) can be
summarized as follows:
• Prostate/Target coverage constraint: V100 ≥ 90% of the volume.
• Urethra constraint: D10 < 118% of the prescription dose.
• Bladder constraint: V75 < 1 cc.
• Rectum constraint: V75 < 1 cc.
Note:
(1) Vx refers to the absolute volume that receives x% of the prescription dose, and
Dx refers to the percent of the prescription dose that covers x% of the volume.
(2) In this study, a more stringent set of criteria was introduced. It is designated
by the RTOG+ symbol and is the same as the RTOG criteria set except that it specifies
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a higher target coverage requirement of 95% for the V100. This is usually attainable in
the clinic without sacrificing the OAR protection.
2.3.2 gMCO algorithm Compared with our previous studies (Cui et al 2018a, Cui et
al 2018b), there are three main differences in gMCO: (1) the trade-off between target
and urethra is now explored, (2) the Pareto surfaces are widely explored with a large
number of plans, as no prior knowledge of the RTOG+ valid solution space is involved,
and (3) the validation cases were used to determine the number of parallel plans (from
1 to 10 000) needed to achieve high RTOG and RTOG+ acceptance rates with random
hidden weights. In gMCO, the parallel plan computations were executed with gL-BFGS.
2.4 Comparison between clinical plans and gMCO plans
A plan pool was created with the gMCO algorithm. One plan was selected from the
plan pool and was referred to as the gMCO plan.
The criteria used for plan selection are, in descending order of priority: RTOG+
valid plan, RTOG valid plan, RTOG invalid plan (violates at least one criteria). If
multiple RTOG or RTOG+ valid plans existed, the one with a highest target V100 was
selected. If multiple RTOG invalid plans existed, the one with the lowest bladder and
rectum V75 (while not violating the criteria for target and urethra) was selected.
2.4.1 Dosimetric performance The dosimetric results of clinical plans were retrieved
from Oncentra Brachy (Elekta Brachy, Veenendaal, The Netherlands). Dosimetric
comparisons between clinical plans and gMCO plans were analyzed for 462 test cases.
The overall result was examined based on RTOG and RTOG+ acceptance rates (the
criteria of all organs were met). The acceptance rate (i.e. target V100, urethra D10,
bladder V75, and rectum V75) for each organ was also reported.
2.4.2 Planning time The planning time consists of the time taken for dose calculation
points creation, dose rate matrix calculation, optimization, and DVH calculation on
GPU. The calculation time of each portion was recorded for gMCO plans. The total
planning time was compared between clinical plans and gMCO plans.
3 Results
3.1 GPU-based optimization engines
3.1.1 Equivalence between the four optimizers The optimization processes of the four
optimizers for one random validation case are illustrated in figure 2. From this figure, (1)
gL-BFGS plans obtained with different initial dwell times converge to the SA objective
function value, (2) no significant differences (within 0.02%) in objective function values
resulted from the four optimizers were observed. Over all 100 validation cases, similar
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results were observed, because the final objective function values of the four algorithms
were in agreement within 0.2%.
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Figure 2: Illustration of cSA, gSA, cL-BFGS and gL-BFGS objective function values
against the number of iterations for one random validation case. (The difference between
CPU and GPU random number generators accounts for the different trajectories for cSA
and gSA).
3.1.2 Pareto surfaces characterization with gSA and gL-BFGS To characterize Pareto
surfaces, 100 000 different solutions were generated with gSA and gL-BFGS (1000
solutions/case for all 100 validation cases). For gSA, the mean fraction of non-dominated
solutions was 99.6% under 50 000 iterations.
For gL-BFGS, the results in figure 3a indicate that the fraction of non-dominated
solutions decreased (from 100% to 89.3%) as the stopping criteria increased (from
 = 10−7 to  = 10−2). On the other hand, the speedup factor in the optimization time
increased (from 1 to 10) as the stopping criteria increased (from  = 10−7 to  = 10−2).
It should be noted that over 99.3% of the solutions obtained with a larger stopping
criteria ( = 10−3) are Pareto optimal solutions. Given that reaching optimality and a
reasonable calculation time are important criteria for clinical applicability, the results
in figure 3a suggest that there could be a time advantage in using a larger stopping
criteria ( = 10−3).
Furthermore, a single 2D Pareto surface characterization with gSA and gL-BFGS is
shown in figure 3b. The results suggest that no significant difference in Pareto surfaces
approximations is observed with GPU-based optimization engines under clinically useful
stopping criteria and under more strict stopping criteria as specified in section 2.2.3.
From these results,  = 10−3 is used as the stopping criteria in gL-BFGS afterwards.
3.1.3 Computational performance under clinically useful scenarios Under clinically
useful scenarios, the optimization time of cSA, gSA, cL-BFGS and gL-BFGS are shown
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Figure 3: (a) Effect of the stopping criteria on the fraction of non-dominated solutions
in the Pareto front characterized with gL-BFGS (black solid line) and the speedup factor
of the optimization time (red dashed line). The speedup factor are normalized to the
values obtained with a stopping criteria of  = 10−7. (b) A comparison of 2D Pareto
surface approximations with gSA and gL-BFGS optimization engines for a random case.
(fT is denoted for target individual objective function and fR is denoted for rectum
individual objective function).
in figure 4a. From the results, the time of all four engines increased as the number
of plans increased. For 1000 plans, the mean optimization time was 9.2 s/plan (cSA),
60 ms/plan (gSA), 1 s/plan (cL-BFGS), and 0.9 ms/plan (gL-BFGS). In other words,
compared with the cSA result, cL-BFGS can achieve a speedup factor up to 9, gSA can
achieve a speedup factor of up to 176, and gL-BFGS can achieve a speedup factor of up
to 10 990.
Figure 4b shows that the mean GPU memory usage increased with the number of
plans for the GPU algorithms, and that the increase rate becomes significantly large
when the number of plans reaches approximately 1000.
3.2 Patient-specific multi-criteria optimization algorithm
As the hidden weights were randomly generated in gMCO algorithm, the RTOG and
RTOG+ acceptance rates were measured multiple times with different random hidden
weight vectors in equation (4). In figure 5, the RTOG+ acceptance rate increases (from
17% to 85%) and the spread of the acceptance rate distributions decreases with the
number of plans. However, a number of 1000 plans was selected as the best compromised
between optimization time (which increases after 1000 plans, see figure 4a) and the
RTOG+ acceptance rate (which does not increase significantly after 1000 plans) for
gMCO algorithm.
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Figure 4: Computational performance against the number of plans for cSA, gSA, cL-
BFGS and gL-BFGS under clinically useful scenarios (cSA and gSA: 1000 iterations,
cL-BFGS and gL-BFGS:  = 10−3): (a) the mean optimization time, (b) the mean
GPU memory usage of gL-BFGS (the result of gSA was ignored, for its similarity to the
gL-BFGS one).
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Figure 5: The effect of the number of plans on RTOG and RTOG+ acceptance rates
for gMCO (including the spread of the distributions in the boxes).
3.3 Comparison between clinical plans and gMCO plans
3.3.1 Dosimetric performance The dosimetric comparison between clinical plans and
gMCO plans is illustrated in figure 6. These results suggest that the mean target
coverage was higher for gMCO plans (97.2%) than for clinical plans (95.3%). The mean
urethra D10 was significantly higher for gMCO plans (115.7%) than for clinical plans
(109.1%). The mean bladder V75 was 0.53 cc for clinical plans, and 0.78 cc for gMCO
plans. For rectum sparing, the mean rectum V75 was 0.56 cc for clinical plans, and
0.52 cc for gMCO plans.
The acceptance rate results are summarized in table 2. For overall dosimetric
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Figure 6: Dosimetric comparison between IPSA physician-approved plans and gMCO
plans over the test cohort: (a) target V100, (b) urethra D10, (c) bladder V75, and (d)
rectum V75.
performances, the number of RTOG valid plans was 428 (92.6%) for clinical plans, and
461 (99.8%) for gMCO plans. The number of RTOG+ valid plans was 288 (62.3%) for
clinical plans, and 414 (89.6%) for gMCO plans.
Table 2: RTOG and RTOG+ acceptance rates (%) for clinically approved plans and
gMCO plans over 462 test cases.
RTOG RTOG+
Time
Target Bladder Rectum Urethra All Target All
Clinical 99.8 95.2 98.7 98.5 92.6 64.1 62.3 mins
gMCO 100.0 99.8 100.0 100.0 99.8 89.6 89.6 9.4 s
The number of plans with a target coverage greater than 95% was 296 (64.1%) for
clinical plans, and 414 (89.6%) for gMCO plans. The number of plans that exceeded the
urethra sparing constraint was 7 for clinical plans, and 0 for gMCO plans. The number
of plans that exceeded the bladder sparing constraint was 22 for clinical plans, and 1
for gMCO plans. The number of plans that exceeded the rectum sparing constraint was
6 for clinical plans, and 0 for gMCO plans. In addition, the mean number of RTOG
valid plans was 617/1000 (61.7%), and the mean number of RTOG+ valid plans was
268/1000 (26.8%) for the gMCO plan pool.
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As a supplement to the general comparisons described above, one example case was
chosen to illustrate the advantage of gMCO in terms of the results of DVHs and isodose
curves in figure 7.
(b) (c)
clinical	plan
Target 𝑉"##:			93.5	%
Urethra 𝐷"#:	121.3	%
Bladder 𝑉%&	:			0.05	cc
Rectum 𝑉%&	:			0.28	cc
gMCO	plan
Target 𝑉"##:			96.6	%
Urethra 𝐷"#:	117.8	%
Bladder 𝑉%&	:			0.76	cc
Rectum 𝑉%&	:			0.22	cc
(a)
clinical gMCO
Figure 7: A comparison between the clinical plan and the gMCO plan for one example
case: (a) DVHs and dosimetric parameters, (b) and (c) isodose curves.
3.3.2 Planning time The time to create a plan is of the order of a few minutes in
clinic, including manual tweaking of the objective function and/or dwell times. On
the other hand, the mean planning time was 9.4 s for gMCO to generate 1000 optimal
plans. Among these numbers, the mean dose calculation points creation time was 7.4 s,
which represents 79% of the mean planning time. The mean optimization time was
0.8 s (8.5% of the mean total planning time). Dose rate matrix calculation and DVH
calculation on GPU contribute to the rest of the mean planning time. In addition,
automatically plan selection from the plan pools was performed in batch for 462 cases,
and the corresponding time was negligible (4.2 s for plan selection for 462 cases).
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4 Discussion
Our recent studies (Cui et al 2018a, Cui et al 2018b) showed that it is possible to
obtain a RTOG valid plan without any user interventions. In order to further increase
the planning efficiency, four optimization engines were implemented and compared. Our
results indicated that (1) gSA and gL-BFGS can speedup the optimization time by two
or three orders of magnitude compared to their CPU implementation (figure 4a), (2) L-
BFGS is equivalent to simulated annealing, and is not trapped in local minima (figure 2),
(3) gL-BFGS is able to compute 10 000 plans within 9 s (optimization time in figure 4a),
and (4) the multi-GPU approach is not necessary, considering the fact that the mean
GPU memory usage to generate 10 000 plans was 2.6 GB out of 12 GB (figure 4b).
A new patient-specific approach called GPU-based MCO (gMCO) was proposed
as an upgrade of our prior studies (Cui et al 2018a, Cui et al 2018b). gMCO can
increase the RTOG acceptance rate from 97.5% (Cui et al 2018b) to 99.8%, and can
decrease the planning time from 1 h (300 plans) (Cui et al 2018a), to 41 s (14 relevant
plans) (Cui et al 2018b), to 9.4 s (1000 plans). Compared with the IPSA physician
approved plans, gMCO can increase the RTOG+ acceptance rate by 27.3%, eliminating
around 10 manual tweaking needed to achieve the observed clinical level based on the
results presented in figure 5. For example, a RTOG invalid plan (urethra D10 above
118%) can be escalated to a RTOG+ valid plan by using gMCO. This has been made
possible by relaxing the the bladder V75 dose (still below 1 cc), while still meeting all
requirements for target, urethra and rectum dose parameters as shown in figure 7a. Such
information can also be seen from the isodose curves in figure 7b-c. Note that in this
study, the trade-off involved in the automatic selection scenario is based on selecting
the highest target V100 while satisfying all the other RTOG criteria (figure 6). However,
a high quality gMCO plan pool is available for the user to pick a plan that best suits
the patient-specific conditions.
KBP and MCO are widely used patient-specific inverse planning algorithms. In
KBP, clinical plans were used to extract the regression models based on geometric
features. However, clinical plans are user-dependent (Das et al 2008), and may
be inconsistent between centers (Chung et al 2008). On the other hand, gMCO is
independent of these issues. In MCO, even though interpolations between calculated
plans were usually used to achieve a high planning efficiency, ultra-fast planning remains
a challenge since no parallelization scheme was implemented. In this study, it only
takes 9.4 s to generate a high quality plan pool with gMCO. However, it is admitted
that these comparisons were made by ignoring that the dwell times optimization in
HDR brachytherapy is a relatively small scale problem compared to the fluence map
optimization in EBRT.
Note that for the objective function considered in this work, the solution space is
convex and it would be easy to dismiss SA in favor of the more computationally efficient
gL-BFGS algorithm. While this objective function is popular in the field, other types
of objective function might have more complex solution spaces. Therefore, having a
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robust, albeit slower, MCO algorithm based on SA remains an essential tool.
We anticipate that the approach proposed in this study will be implemented in
clinical systems as an adjunct tool. In future work, the application of gL-BFGS as well
as gMCO to other HDR brachytherapy sites will be investigated.
5 Conclusion
Two GPU-based optimization engines were designed to calculate multiple plans in
parallel. With the preferred engine, an ultra-fast patient-specific planning tool that is
able to generate a high quality plan without any user interventions was proposed. After
a validation over a large-scale patient cohort, both plan quality and planning efficiency
can be significantly improved compared with the traditional planning in clinic.
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